SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing intense volatility and a sharp sell-off following a significant double miss on earnings and weak forward guidance. The community is sharply divided between investors arguing that the stock is a deep-value turnaround play given its cash-rich balance sheet and others expressing deep frustration with management, with many actively debating the impact of executive turnover and the company's long-term competitive moat.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging as investors react to reports of potential U.S. restrictions on Chinese optical transceivers, a move that could significantly boost domestic suppliers of critical AI infrastructure components. The market is also heavily focused on the company's upcoming earnings report, with sentiment driven by expectations for accelerated 800G and 1.6T product growth alongside aggressive manufacturing capacity expansion in Texas.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging following a blowout second-quarter earnings report that featured record revenue and improved margins, signaling a clear turning point for the company's commercial execution. Investors are actively discussing the massive upside potential from the pipelineparticularly upcoming lung cancer datawhile celebrating the stock's break above key resistance levels as short sellers scramble to cover their positions.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant investor interest as the community braces for an upcoming earnings release, with many traders betting on a short squeeze fueled by high institutional ownership, a significant short interest ratio, and persistent rumors of a potential take-private buyout. While some retail investors are aggressively accumulating shares and calls in anticipation of a turnaround, bears remain skeptical, citing concerns over fast-food market saturation and the potential for dividend sustainability amid the company's global expansion efforts.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is drawing significant attention as investors weigh the company's recent government-backed expansion and technological milestones against broader concerns regarding its high cash burn and speculative valuation. The community remains deeply divided, with bulls pointing to strategic partnerships and long-term quantum potential while bears continue to scrutinize the stock's volatility and reliance on government funding.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investor sentiment turns sharply negative following disappointing earnings results and growing frustration over the company's shift into AI infrastructure without securing promised tenant deals. The community is heavily focused on the CEO's compensation, significant insider selling, and concerns that the company's operational execution is failing to deliver value to long-term shareholders.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is currently the focus of intense investor debate following a delayed FDA decision regarding its RP1 candidate, with the community actively speculating on the probability of a third complete response letter versus a conditional approval. Despite a positive advisory committee vote, the ongoing silence from the company and the FDA has fueled concerns about potential dilution, capital requirements, and the long-term commercial viability of the therapy compared to existing oncology alternatives.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending as its stock price surged following a strong earnings report that topped expectations, with investors closely watching the company's cloud and AI-driven growth metrics. While community sentiment is divided between bulls celebrating a potential sector recovery and skeptics pointing to persistent GAAP losses, the stock remains a central focus for traders gauging the resilience of enterprise software in an AI-dominated market.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare shares are experiencing heightened volatility and intense community discussion following a significant after-hours price surge that followed a quarterly earnings beat and upward guidance. Investors are actively debating the company's high valuation multiples versus its dominant role in internet infrastructure and emerging AI agent connectivity, with many highlighting the stock as a battleground between long-term growth believers and valuation-focused short sellers.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh the impact of recent sector-wide weakness against the company's upcoming earnings report, with community discussion intensely focused on whether strong user growth can offset disappointing revenue and competitive pressure. Investors are actively debating the company's valuation, the long-term potential of its new prediction market offerings, and the broader fallout from competitor earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Veradermics (MANE) Positioned to Disrupt Hair Loss Market

Veradermics?(MANE) Positioned to Disrupt Hair Loss Market...

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study 302 in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced the presentation of data from the Phase 2/3 Study 302 of VDPHL01 in male patients with mild-to-moderate pattern...

Why Is MANE Stock Rising Today?

Equity

In Veradermics’ Phase 2 trial for VDPHL01, female subjects showed an increase in hair count as early as the second month of treatment.


Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months

Veradermics reported positive phase 2 data for VDPHL01, showing hair growth and favorable safety in women with pattern hair loss.read more...

PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition proposal, other big gains from Aehr Test, Electrovaya, Robo.ai, Falcon's Beyond, Veradermics, Lucid Group, Kopin, MINISO, Mesoblast, Nexstar, Lionsgate, Karman.read more...

Veradermics Oral VDPHL01 Delivers Positive Study 207 Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study 306 Readout

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced positive topline results from its open-label Phase 2 clinical trial (Study 207) evaluating VDPHL01, a...

Veradermics to Hold Conference Call to Discuss Study 207 Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast on Wednesday, July 15, 2026 at 8:00 am ET to review results from...

Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Veradermics (MANE) points to a 27.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Veradermics to Present at Upcoming June Investor Conferences

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that company management will participate in the following upcoming investor conferences in June...

Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 302 Study of VDPHL01 at the 2026 World Congress for Hair Research

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that topline results from Phase 2/3 302 Study of VDPHL01 will be presented at the 2026 World Congress...

Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company was founded in 2019 and is headquartered in New Haven, CT.

Veradermics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MANEVeradermics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest MANE News